- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04795492
Effect of Remote Intervention in Patients With SCAD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: This study is intended to verify the effect of a remote intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease.
Study design: The study was a multicenter, two-arm, parallel, open-label, prospective clinical trial that evaluated the effect of a remote intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease with 1 year of follow-up.
Study intervention: Participants in the experimental group received remote guidance from the cardiac rehabilitation team in the community hospital every month after enrollment. The control group had no special intervention. All patients received follow-up at 6 months and 1-year follow-up.
Outcome measures: The primary outcome was medication adherence. Secondary outcomes included smoking, drinking, blood pressure, body mass index, LDL cholesterol, HbA1c, and major adverse cerebral cardiovascular events(MACCE). Medication compliance consists of the following five medications: aspirin, P2Y12 receptor antagonist, statin, ACEI/ARB and beta-blocker.
Statistical analysis: Values of analyzed endpoints between intervention group and control group will be compared according to the analysis plan. We'll follow a prespecified analysis plan and subgroup analysis will be conducted accordingly.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Boqun Shi, MD
- Phone Number: +8615130119516
- Email: shiboqun@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100000
- Fuwai Hospital, Chinese Academy of Medical Science; National Center for Cardiovascular Diseases
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged between 18-99 years
- Diagnosed with SCAD according to guidelines by coronary CTA or coronary angiography (including stable angina, ischemic cardiomyopathy, and the stable course after acute coronary syndrome)
- Have sufficient Chinese language proficiency to reading, speaking and listening
- Live with at least one caregiver or guardian in the household
- Presence of stable hemodynamics without using vasopressor
- Able to individually consent
- Not participating in any other clinical trial
Exclusion Criteria:
- Unable to provide informed consent
- Unable to be involved in clinical follow-up and treatment
- Suffered comorbidity with a life expectancy of less than 1 year
- Have contra-indication to cardiac rehabilitation
- Acute coronary syndrome
- History of noncompliance with medical therapy
- Severe valvular disease or valvular disease likely to require surgery or percutaneous valve replacement during the trial
- Planned major surgery necessitating interruption of antiplatelet therapy
- Inability to comply with the protocol
- Has any condition that, in the opinion of the investigator, would make participation not be in the best interest of the subject or that could prevent, limit or confound the protocol-specified assessments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Remote intervention
|
Medication adherence and risk factor modification status were assessed, then individualized feedback, encouragement and recommendations were provided.
Risk factor modification included lipid control, smoking and drinking cessation, BP monitoring, dietary change keeping a healthy weight and in our trial.
There were also a lot of educational materials about coronary heart disease knowledge that were reviewed by cardiologists, and participants were free to provide them whenever and wherever they want.
|
Active Comparator: Control group
Routine outpatient follow-up
|
Participants in this group received standard outpatient cardiology follow-up with formal cardiac rehabilitation and secondary prevention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medication adherence
Time Frame: 1 year
|
Compliance and administration of cardiovascular protective drugs
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c
Time Frame: 1 year
|
standard protocol
|
1 year
|
Blood Pressure
Time Frame: 1 year
|
BP was measured twice by an electronic device after 10 min of seated rest and calculated as the mean of 2 measurements
|
1 year
|
Body Mass Index
Time Frame: 1 year
|
standard protocol
|
1 year
|
LDL Cholesterol
Time Frame: 1 year
|
standard protocol
|
1 year
|
Smoking
Time Frame: 1 year
|
self-reported
|
1 year
|
Drinking
Time Frame: 1 year
|
self-reported
|
1 year
|
Aspirin
Time Frame: 1 year
|
self-reported
|
1 year
|
P2Y12 receptor antagonist
Time Frame: 1 year
|
self-reported
|
1 year
|
Statin
Time Frame: 1 year
|
self-reported
|
1 year
|
ACEI/ARB
Time Frame: 1 year
|
self-reported
|
1 year
|
Beta-blocker
Time Frame: 1 year
|
self-reported
|
1 year
|
MACCE
Time Frame: 1 year
|
acute myocardial infarction, acute heart failure, rehospitalization for cardiovascular event, stroke, death from any cause, death from a cardiovascular cause and unplanned revascularization
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Weihua Song, MD, Fuwai Hospital, Chinese Academy of Medical Science; National Center for Cardiovascular Diseases
Publications and helpful links
General Publications
- Zheng X, Spatz ES, Bai X, Huo X, Ding Q, Horak P, Wu X, Guan W, Chow CK, Yan X, Sun Y, Wang X, Zhang H, Liu J, Li J, Li X, Spertus JA, Masoudi FA, Krumholz HM. Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial. Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005616. doi: 10.1161/CIRCOUTCOMES.119.005616.
- Yu C, Liu C, Du J, Liu H, Zhang H, Zhao Y, Yang L, Li X, Li J, Wang J, Wang H, Liu Z, Rao C, Zheng Z; MISSION-2 Collaborative Group. Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization. Am Heart J. 2020 Oct;228:17-26. doi: 10.1016/j.ahj.2020.06.019. Epub 2020 Jul 4.
- Chen X, Zhou X, Li H, Li J, Jiang H. The value of WeChat application in chronic diseases management in China. Comput Methods Programs Biomed. 2020 Nov;196:105710. doi: 10.1016/j.cmpb.2020.105710. Epub 2020 Aug 14.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERIP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Ischemia
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
University of Roma La SapienzaCompletedRosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) (ROMA)Periprocedural Myocardial NecrosisItaly
-
University Hospital "Sestre Milosrdnice"CompletedSTEMI - ST Elevation Myocardial Infarction | Myocardial ReperfusionCroatia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Tomsk National Research Medical Center of the Russian...CompletedMyocardial Infarction | Myocardial Injury | STEMI | Myocardial NecrosisRussian Federation
-
Deutsches Herzzentrum MuenchenCompletedInfarction, MyocardialGermany
-
Lokien van NunenMaquet Cardiovascular; Stichting Toegepaste Wetenschappen (project number 11052)CompletedAcute Myocardial Infarction | Persisting Ischemia | No ReflowNetherlands
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
University Hospital, ToulouseThoratec CorporationWithdrawnChronic Myocardial IschemiaFrance
-
Foundation IRCCS San Matteo HospitalFondazione Poliambulanza Istituto Ospedaliero; Azienda Ospedaliera Ordine Mauriziano... and other collaboratorsWithdrawnST-elevation Myocardial InfarctionItaly
Clinical Trials on remote intervention
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingSubstance Use | Violence in Adolescence | Violence | Criminal BehaviorUnited States
-
Icahn School of Medicine at Mount SinaiEdward-Elmhurst Health SystemActive, not recruiting
-
British Columbia Cancer AgencyUnknownQuality of Life
-
Qianfoshan HospitalNot yet recruitingUltrasonography | Breast Carcinoma | Breast Neoplasm Female | Health Education
-
University Hospital Schleswig-HolsteinCompletedChronic Wound | Burn Injury | Acute WoundGermany
-
University of California, Los AngelesUniversity of California, San Diego; University of California, Davis; University... and other collaboratorsCompleted
-
University of FloridaNational Institute on Aging (NIA)RecruitingLow Back PainUnited States
-
University of Nevada, Las VegasCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom